<DOC>
	<DOCNO>NCT00571818</DOCNO>
	<brief_summary>The purpose study understand pancreas function transplantation particularly high blood sugar level develop . It also analyze effect medicine use prevent rejection blood sugar level . The hypothesis test hyperglycemia six month successful pancreas transplant result defect insulin secretion , insulin resistance , .</brief_summary>
	<brief_title>The Prospective Evaluation Pancreatic Function Pancreas Transplant Recipients</brief_title>
	<detailed_description>Type I diabetes mellitus ( DM1 ) autoimmune disease characterized destruction sulin-secreting beta cell . Insulin replacement cornerstone therapy patient DM1 . However , pancreas transplantation , utilizing whole pancreas mean replace destroyed beta cell , become therapeutic alternative . The goal pancreas transplantation establishment long-term euglycemia , thereby prevent allow repair end-organ complication . Maintenance pancreas allograft many year remain goal follow pancreas transplant recipient time . The onset hyperglycemia less one year transplant usually due issue surgical technique acute rejection . HOwever , onset hyperglycemia fter one year pancreas transplant problematic underlying cause less clear less well characterize . Currently , protocol definitively identifying cause hyperglycemia pancreas transplant recipient one year . This project systematically characterize beta cell function peripheral tissue response insulin patient receive earlier successful pancreas transplant develop hyperglycemia .</detailed_description>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>Hyperglycemic pancreas transplant recipient : age 1965 receive pancreas transplant ≥ 9 month previously fast glucose level ≥ 126 mg/dl hemoglobin A1C &gt; 1 % normal Euglycemic pancreas transplant recipient : age 1965 receive pancreas transplant ≥ 9 month previously fast glucose level &lt; 126 mg/dl normal HbA1C without take medication treatment high blood sugar . Euglycemic Kidney Transplant Recipients : age 1965 prior diagnosis diabetes receive kidney transplant ≥ 9 month previously show continued function Euglycemic Healthy Control Subjects : age 1965 diabetes renal disease Hyperglycemic pancreas transplant recipient : chronic illness would decrease insulin sensitivity ( terminal illness BMI &gt; 30 kg/m2 serum creatinine &gt; 2 mg/dl hemoglobin &lt; 10 g/dl episode acute rejection precede 3 month entry . Euglycemic pancreas transplant recipient : Exclusion criterion hyperglycemic transplant patient . diagnosis type 2 diabetes . Euglycemic Kidney Transplant Recipients : Exclusion criterion euglycemic pancreas transplant recipient . Euglycemic Healthy Control Subjects : chronic illness medication know affect glucose metabolism history smoke serum creatinine ≥ 1.5 mg/dl BMI &gt; 30 kg/m2 .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>euglycemic</keyword>
	<keyword>transplant</keyword>
	<keyword>pancreas</keyword>
	<keyword>hyperglycemic</keyword>
	<keyword>kidney</keyword>
</DOC>